Metraipolis › archive › dc_bf116a814d41

Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease — Europe PMC PMID:42797321

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42797321
DOI: 10.3390/pharmaceutics18091146
License (as archived): solo-consultazione
Archived: 2026-10-10T03:35:25.668Z
SHA-256 of the archived text: 2d999a38c0fb3a6c80c8698ab5209fd11f3fb8498eb55666116a537c137a608d
Stable URL of this page: https://metraipolis.com/documento/dc_bf116a814d41

How to cite

Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease — Europe PMC PMID:42797321 — Europe PMC (en), https://europepmc.org/article/MED/42797321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf116a814d41 (Metraipolis archive dc_bf116a814d41, sha256 2d999a38c0fb3a6c80c8698ab5209fd11f3fb8498eb55666116a537c137a608d)

BibTeX

@misc{dcbf116a814d41,
  title = {Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease — Europe PMC PMID:42797321},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797321},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf116a814d41; sha256 2d999a38c0fb3a6c80c8698ab5209fd11f3fb8498eb55666116a537c137a608d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797321. Agents can read the archived copy with the MCP tool read_document.